Dermata Therapeutics Inc (DRMA) — Defensive Interval Ratio

Latest as of December 2023: 2 days

Dermata Therapeutics Inc (DRMA) has a Defensive Interval Ratio of 2 days as of December 2023. Defensive assets of $8.36K (cash $-, short-term investments $-, receivables $8.36K) cover 2 days of daily cash needs of $4.45K/day. Check DRMA intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

2 days
Days of operational coverage

Defensive Assets

$8.36K
Cash + ST Investments + Receivables

Daily Cash Need

$4.45K
Current Liabilities ÷ 365

Current Liabilities

$1.62 Million
USD

Dermata Therapeutics Inc Defensive Interval Ratio (2022–2024)

This chart shows how Dermata Therapeutics Inc's Defensive Interval Ratio has evolved across 3 annual periods from 2022 to 2024. As of December 2023, the ratio stands at 2 days, meaning defensive assets of $8.36K can fund 2 days of operations without new revenue. Also explore net asset growth rate of Dermata Therapeutics Inc to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Dermata Therapeutics Inc (2022–2024)

The table below presents the year-by-year Defensive Interval Ratio for Dermata Therapeutics Inc from 2022 to 2024, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Dermata Therapeutics Inc (DRMA) market capitalisation.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2024 584359 days $3.16 Billion $5.40K/day $- $3.16 Billion ▲ +584357 days
2023 2 days $8.36K $4.45K/day $- $- ▼ -3 days
2022 5 days $12.60K $2.53K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)